That's Nice

We had the opportunity to interview Jayne Shaw, Co-Founder and Executive Chair of BCAL Diagnostics, as part of Road to the Max: Australia. BCAL Diagnostics is a biotechnology screening and diagnostic company focused on revolutionizing breast cancer detection. Jayne shared the company’s mission to achieve early and accurate diagnoses, with the goal of facilitating early intervention and ultimately improving outcomes for women. Through their innovative approach, BCAL Diagnostics is dedicated to advancing breast cancer screening technology and empowering women with better health outcomes. Thank you, Jayne, for sharing BCAL’s inspiring work in the fight against breast cancer! Check out the full interview and the rest of the road trip: https://lnkd.in/eG6HWq5U John Hurrell Ph.D. | Shane Ryan | Simon Preston | Alexandra Feetham | Kim Kirkham | Merilyn Sleigh #roadtothemax #madmax #pharmaindustry #pharma #lifescience #biotech #clinicaltrials #australia

We had the privilege of interviewing Dr. Rachel de las Heras, Ultrasound Product Development Manager at the UQ Queensland Brain Institute (QBI), as part of our Road to the Max: Australia journey. Located on The University of Queensland campus in Brisbane, QBI is dedicated solely to understanding the fundamentals of how the brain works, with a mission to translate this knowledge into new treatments. Dr. de las Heras shared insights into QBI’s groundbreaking research, which paves the way for innovative therapies for brain diseases, neurodegenerative conditions, psychiatric disorders, and beyond. Her team’s work exemplifies the incredible potential of neuroscience to improve patient outcomes and tackle some of the most challenging health issues of our time. Thank you, Rachel, for an inspiring conversation about the future of brain research! Check out the full interview and the rest of the road trip: https://lnkd.in/ejnbfDgb Pankaj Sah | Beverley Trivett AM | Andrea Markey #roadtothemax #madmax #pharmaindustry #pharma #lifescience #biotech #clinicaltrials #australia #brisbane

We had a great interview with Mark W. Womack, CEO of BioCina, during our Road to the Max: Australia journey. BioCina, a specialized CDMO for biotherapeutics, recently expanded into Australia, drawn by the country’s supportive government policies, strong infrastructure, and universities’ commitment to advancing clinical trials. Mark shared BioCina’s excitement about this expansion, as the company plans to add mammalian production capabilities alongside their existing microbial, plasmid DNA, and mRNA capabilities. BioCina’s growth reflects Australia’s increasing role in global biotherapeutics development, and we’re thrilled to see what the future holds for their innovative work. Thank you, Mark, for sharing BioCina’s vision and the promising landscape of biopharma in Australia! Check out the full interview and the rest of the road trip: https://lnkd.in/ePhPTA-a Michael Tsaconas | Jan Bekker | Anthony Morgan | Rik Quaghebeur | Melissa El Khouri | Alex Pomerantz #roadtothemax #madmax #pharmaindustry #pharma #lifescience #biotech #clinicaltrials #australia

We had an insightful conversation with John Wrenn, Director of Operations, Australia & New Zealand at CAI during our Road to the Max: Australia journey. CAI brings its expertise in complex project management, no-code technology, commissioning, compliance, training, and operational workflows to support clients in Australia and the APAC region. John shared how CAI helps companies navigate the regulatory landscape for clinical trials, ensuring their projects run smoothly from start to finish. By providing critical support across the entire operational workflow, CAI is helping life sciences companies bring their innovations to market efficiently and compliantly. Thank you, John, for sharing how CAI is driving excellence in clinical trials and project management! Check out the full interview and the rest of the road trip: https://lnkd.in/eSrfkExj Mike Martin | Roger Ouimet | Chas Carabasi | Andrew Bohlmann | Joseph Nardella | Richard Tree, D.Eng. | Alice Redmond | Sean Sullivan | Joe Robinson, QCxP, CPIP | Edward Horgan | Angel Estrada | Kirk Calhoun | Kelly Smeltzer | Susan Warren | Luis Felipe Mercado | David Tremain, PMP #roadtothemax #madmax #pharmaindustry #pharma #lifescience #biotech #clinicaltrials #australia

We had an insightful conversation with Frank Giampieri, CEO and Founder of Primal Organix, on the Road to the Max: Australia. Primal Organix specializes in developing nutraceutical products made with terpenes — naturally occurring organic compounds found in plant oils. Frank shared Primal Organix’s mission to support positive mental health and well-being through their innovative product line. During the interview, we explored the many benefits of terpenes and even had the chance to sample some of the products firsthand. Thank you, Frank, for introducing us to the potential of terpenes and the exciting work Primal Organix is doing to enhance well-being! Check out the full interview and the rest of the road trip: https://lnkd.in/eGURcUex Mark Garbelotto #roadtothemax #madmax #pharmaindustry #pharma #lifescience #biotech #clinicaltrials #australia

We had a great conversation with Grant Swart, VP & General Manager of Mayne Pharma, as part of our Road to the Max: Australia journey. Mayne Pharma is a leading pharmaceutical company that develops, manufactures, and markets both branded and generic drugs. Grant shared how the company has dedicated significant time, energy, and resources to ensure they can reliably support their partners from Phase I trials through to commercial supply. With a strong focus on expanding their footprint, Mayne Pharma is now looking to grow into the European market, bringing their expertise in drug development and manufacturing to new global partners. Thank you, Grant, for sharing Mayne Pharma’s exciting plans and commitment to innovation in the pharmaceutical space! Check out the full interview and the rest of the road trip: https://lnkd.in/eQnMiceb Matt Menas | Brant Schofield | Tony Ramy | Lynn Sullivan | Daniel Moore | Trudy Boyce | Debra Bourke #roadtothemax #madmax #pharmaindustry #pharma #lifescience #biotech #clinicaltrials #australia

We had a compelling interview with Dr. Christian Toouli, CEO and Managing Director of FivepHusion, during our Road to the Max: Australia journey. FivepHusion is rethinking cancer treatment by addressing challenges in the current standard of care for solid tumors and stage IV cancers. Dr. Toouli shared how the company is modernizing the delivery of standard chemotherapeutic drugs, aiming to provide better outcomes for patients. By reimagining traditional approaches to cancer treatment, FivepHusion is leading the charge in making therapies more effective and safer, helping to improve the lives of those battling cancer. Thank you, Dr. Toouli, for sharing your vision for the future of oncology! Check out the full interview and the rest of the road trip: https://lnkd.in/eSMCYXyt David Ranson | Bill Ketelbey | Natalie Strange | Iain Ross #roadtothemax #madmax #pharmaindustry #pharma #lifescience #biotech #clinicaltrials #australia

We had an enlightening visit to the University of New South Wales (UNSW) campus as part of Road to the Max: Australia, where we interviewed Professor Merlin Crossley, Deputy Vice-Chancellor of Academic Quality at UNSW, Dr. Paul Watt, Executive Chairman & CSO at Avicena Systems, and Professor Ewa Goldys, Scientia Professor at UNSW. Professor Crossley shared UNSW’s 75-year mission of driving innovation and the groundbreaking work being done in their labs to tackle genetic diseases. Dr. Watt provided more insights into Avicena’s cutting-edge diagnostic systems, and Professor Goldys took us on a deep dive into UNSW’s exciting partnership with Avicena, showing how their collaboration is pushing the boundaries of biosecurity and diagnostics. Thank you to Merlin, Paul, and Ewa for sharing how UNSW and Avicena are advancing research and innovation in the life sciences! Check out the full interview and the rest of the road trip: https://lnkd.in/eZJWRGuU Tony Fitzgerald | Peter White | Angelica Merlot | #roadtothemax #madmax #pharmaindustry #pharma #lifescience #biotech #clinicaltrials #australia

We had the pleasure of interviewing Tony Fitzgerald, CEO of Avicena Systems, and Paul Watt, Executive Chairman and CSO, as part of our Road to the Max: Australia journey. Avicena Systems is leading the charge in biosecurity preparedness with their scalable rapid molecular diagnostics platform, designed to help nations and organizations quickly identify and contain potential outbreaks. Tony and Paul shared how Avicena’s innovative solution is helping build resilient systems that can address emerging pathogens before they spread. Drawing lessons from the pandemic, their platform is designed to respond to the speed at which pathogens can spread among humans and animals, offering a critical tool in safeguarding global health. Thank you, Tony and Paul, for sharing how Avicena is shaping the future of biosecurity and pandemic preparedness! Check out the full interview and the rest of the road trip: https://lnkd.in/e49AV87N Mark Sheridan | John Tarrant | Paul Ostergaard | Shane Stone | Robert Dewhurst #roadtothemax #madmax #pharmaindustry #pharma #lifescience #biotech #clinicaltrials #australia

We had a fascinating interview with Tim Oldham, Ph.D., CEO and Managing Director of AdAlta Ltd, on the campus of La Trobe University in Melbourne as part of Road to the Max: Australia. Tim shared insights into AdAlta's innovative i-body platform, which is making waves in the development of treatments for debilitating diseases. An i-body is a next-generation human protein with superior capabilities compared to traditional monoclonal antibodies, particularly in accessing grooves and cavities that many other antibodies cannot reach. This breakthrough platform opens new doors for targeting complex diseases and advancing therapeutic solutions where traditional methods fall short. Thank you, Tim, for sharing how AdAlta is pushing the boundaries of what’s possible in biotech and disease treatment! Check out the full interview and the rest of the road trip: https://lnkd.in/eBCjme-8 Angus Tester | Khamis Tomusange, Ph.D. | Michael Foley #roadtothemax #madmax #pharmaindustry #pharma #lifescience #biotech #clinicaltrials #australia #melbourne